OBJECTIVE: ATP released from human erythrocytes in response to reduced oxygen tension (pO(2)) participates in the matching of oxygen (O(2)) supply with need in skeletal muscle by stimulating increases in blood flow to areas with increased O(2) demand. Here, we investigated the hypothesis that hyperinsulinemia inhibits ATP release from erythrocytes and impairs their ability to stimulate dilation of isolated arterioles exposed to decreased extraluminal pO(2). MATERIALS AND METHODS: Erythrocyte ATP release was stimulated pharmacologically (mastoparan 7) and physiologically (reduced pO(2)) in the absence or presence of insulin. We also examined the ability of isolated skeletal muscle arterioles perfused with buffer containing erythrocytes treated with insulin or its vehicle (saline) to dilate in response to decreased extraluminal pO(2). RESULTS: Insulin significantly attenuated mastoparan 7- and reduced pO(2)-induced ATP release. In vessels perfused with untreated erythrocytes, low extraluminal pO(2) resulted in an increase in vessel diameter. In contrast, when erythrocytes were treated with insulin, no vasodilation occurred. CONCLUSIONS: These studies demonstrate that insulin inhibits ATP release from erythrocytes in response to reduced pO(2) and impairs their ability to stimulate dilation of skeletal muscle arterioles. These results suggest that hyperinsulinemia could hinder the matching of O(2) supply with need in skeletal muscle.
OBJECTIVE:ATP released from human erythrocytes in response to reduced oxygen tension (pO(2)) participates in the matching of oxygen (O(2)) supply with need in skeletal muscle by stimulating increases in blood flow to areas with increased O(2) demand. Here, we investigated the hypothesis that hyperinsulinemia inhibits ATP release from erythrocytes and impairs their ability to stimulate dilation of isolated arterioles exposed to decreased extraluminal pO(2). MATERIALS AND METHODS: Erythrocyte ATP release was stimulated pharmacologically (mastoparan 7) and physiologically (reduced pO(2)) in the absence or presence of insulin. We also examined the ability of isolated skeletal muscle arterioles perfused with buffer containing erythrocytes treated with insulin or its vehicle (saline) to dilate in response to decreased extraluminal pO(2). RESULTS:Insulin significantly attenuated mastoparan 7- and reduced pO(2)-induced ATP release. In vessels perfused with untreated erythrocytes, low extraluminal pO(2) resulted in an increase in vessel diameter. In contrast, when erythrocytes were treated with insulin, no vasodilation occurred. CONCLUSIONS: These studies demonstrate that insulin inhibits ATP release from erythrocytes in response to reduced pO(2) and impairs their ability to stimulate dilation of skeletal muscle arterioles. These results suggest that hyperinsulinemia could hinder the matching of O(2) supply with need in skeletal muscle.
Authors: Randy S Sprague; Jeffrey J Olearczyk; Dana M Spence; Alan H Stephenson; Robert W Sprung; Andrew J Lonigro Journal: Am J Physiol Heart Circ Physiol Date: 2003-04-10 Impact factor: 4.733
Authors: Stephanie M Benjamin; Rodolfo Valdez; Linda S Geiss; Deborah B Rolka; K M Venkat Narayan Journal: Diabetes Care Date: 2003-03 Impact factor: 19.112
Authors: Wineke Bakker; Pieter Sipkema; Coen D A Stehouwer; Erik H Serne; Yvo M Smulders; Victor W M van Hinsbergh; Etto C Eringa Journal: Diabetes Date: 2007-12-17 Impact factor: 9.461
Authors: Meera Sridharan; Randy S Sprague; Shaquria P Adderley; Elizabeth A Bowles; Mary L Ellsworth; Alan H Stephenson Journal: Exp Biol Med (Maywood) Date: 2010-08-03
Authors: Nicolas Montalbetti; Maria F Leal Denis; Omar P Pignataro; Eiry Kobatake; Eduardo R Lazarowski; Pablo J Schwarzbaum Journal: J Biol Chem Date: 2011-09-15 Impact factor: 5.157
Authors: Christopher G Ellis; Daniel Goldman; Madelyn Hanson; Alan H Stephenson; Stephanie Milkovich; Amina Benlamri; Mary L Ellsworth; Randy S Sprague Journal: Am J Physiol Heart Circ Physiol Date: 2010-03-05 Impact factor: 4.733